Magnesium may be helpful for weight loss. It plays an important role in appetite control, energy metabolism, and blood sugar ...

Prices for insulin, the essential drug for treating diabetes, have plummetted to their lowest levels in a decade following a rise in generic options. Insulin prices averaged 19 cents per unit as of ...

Most of the insulin used by people today is made by bacteria that have been genetically modified to produce insulin that is identical to insulin made in the human pancreas, according to the National ...

Pharmacy closures are accelerating, leaving 45 million Americans in pharmacy deserts. Here's how to fix the problem.

Insulin glargine (Lantus ®, sanofi-aventis) claims to have a 24-hour duration of action. Is there any advantage to using it twice daily? If so, what patient population might benefit from twice-daily ...

A nonprofit in Cambridge, Massachusetts is aiming to make insulin more accessible for diabetes patients in the United States by selling vials of the drug at a fraction of the cost. According to WBZ-TV ...

The U.S. Senate passed a sweeping economic package aimed at lowering healthcare costs and combating climate change on Sunday. The Inflation Reduction Act of 2022 includes a cap on Medicare patients' ...

Lest you think the baby formula shortage occurred overnight or is an isolated problem, think again. It can and will be solved with fewer regulations, a worldwide market, a Trumpian style ...

The American Diabetes Association says insulin prices have skyrocketed in recent years, tripling in price between 2002 and 2013. Senate Bill 827 set $25 caps on copays for the life-saving drug for ...

President Joe Biden signed the Inflation Reduction Act into law this afternoon, with a package that includes sweeping climate and tax initiatives and the biggest change to health care policy since the ...

The Build Back Better bill includes a measure to cap insulin co-pays at $35 a month for people with health insurance. It's an attempt to control the skyrocketing costs of the drug, which isn’t ...

On the heels of Viatris and Biocon Biologics’ landmark diabetes copycat Semglee, another interchangeable biosimilar is crashing the infamously pricey insulin market. Wednesday, the FDA blessed Eli ...